US Patent 8906413 Drug formulations having reduced abuse potential

Patent 8906413 was granted and assigned to Supernus Pharmaceuticals, Inc. on December, 2014 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Current Assignee

‌

Supernus Pharmaceuticals, Inc.

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

8906413

Date of Patent

December 9, 2014

Patent Application Number

10435597

Date Filed

May 12, 2003

Patent Citations Received

‌

US Patent 12109175 Magazines for tactical medicine dispensers

‌

US Patent 11851451 Preparation of psilocybin, different polymorphic forms, intermediates, formulations and their use

‌

US Patent 11865126 Method for treating anxiety disorders, headache disorders, and eating disorders with psilocybin

‌

US Patent 11939346 Preparation of psilocybin, different polymorphic forms, intermediates, formulations and their use

Patent Primary Examiner

‌

Lakshmi Channavajjala

No article content yet.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 8906413 Drug formulations having reduced abuse potential

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API